Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease

American Heart Journal

Volumn 154, Issue 6, 2007, Pages 1035-1042

  Hlatky, Mark A ^a   Quertermous, Thomas ^a   Boothroyd, Derek B ^a   Priest, James R ^a   Glassford, Alec J ^a   Myers, Richard M ^a   Fortmann, Stephen P ^a   Iribarren, Carlos ^b   Tabor, Holly K ^a   Assimes, Themistocles L ^a   Tibshirani, Robert J ^a   Go, Alan S ^b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DIVISION OF RESEARCH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 2;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ANGPT1 GENE; ANIMAL CELL; ARTICLE; CLINICAL FEATURE; CORONARY RISK; FEMALE; FIBROBLAST; GENE; GENETIC RISK; HEART INFARCTION; HIF1A GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RACE DIFFERENCE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STABLE ANGINA PECTORIS; THBS1 GENE; VEGFA GENE; VEGFC GENE; VEGFR2 GENE;

AGED; ANGINA PECTORIS; ANIMALS; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LOGISTIC MODELS; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 36148973202     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.07.042     Document Type: Article

References (23)

1. Semenza G.L., Agani F., Iyer N., et al. Hypoxia-inducible factor 1. From molecular biology to cardiopulmonary physiology. Chest 114 (1998) 40S-45S
2. Yancopoulos G.D., Davis S., Gale N.W., et al. Vascular-specific growth factors and blood vessel formation. Nature 407 (2000) 242-248
3. Stenina O.I., Byzova T.V., Adams J.C., et al. Coronary artery disease and the thrombospondin single nucleotide polymorphisms. Int J Biochem Cell Biol 36 (2004) 1013-1030
4. Go A.S., Iribarren C., Chandra M., et al. Statin and β-blocker therapy and the initial presentation of coronary heart disease. Ann Intern Med 144 (2006) 229-238
5. Taylor-Piliae R.E., Norton L.C., Haskell W.L., et al. Validation of a new brief physical activity survey among men and women aged 60-69 years. Am J Epidemiol 164 (2006) 598-606
6. Iribarren C., Go A.S., Husson G., et al. Metabolic syndrome and early-onset coronary artery disease: is the whole greater than its parts?. J Am Coll Cardiol 48 (2006) 1800-1807
7. Tabor H.K., Risch N.J., and Myers R.M. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 3 (2002) 391-397
8. Wang G.L., Jiang B.H., Rue E.A., et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92 (1995) 5510-5514
9. Shibata T., Giaccia A.J., and Brown J.M. Development of a hypoxia-responsive vector for tumor-specific gene therapy. Gene Ther 7 (2000) 493-498
10. Ryan H.E., Lo J., and Johnson R.S. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 17 (1998) 3005-3015
11. Storey J.D., and Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100 (2003) 9440-9445
12. Hon W.C., Wilson M.I., Harlos K., et al. Structural basis for the recognition of hydroxyproline in HIF-1alpha by pVHL. Nature 417 (2002) 975-978
13. Rossignol F., Vache C., and Clottes E. Natural antisense transcripts of hypoxia-inducible factor 1 alpha are detected in different normal and tumour human tissues. Gene 299 (2002) 135-140
14. Lee S.H., Wolf P.L., Escudero R., et al. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342 (2000) 626-633
15. Kolodgie F.D., Gold H.K., Burke A.P., et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349 (2003) 2316-2325
16. Chen F., Eriksson P., Kimura T., et al. Apoptosis and angiogenesis are induced in the unstable coronary atherosclerotic plaque. Coron Artery Dis 16 (2005) 191-197
17. Tenaglia A.N., Peters K.G., Sketch M.H., et al. Neovascularization in atherectomy specimens from patients with unstable angina: implications for pathogenesis of unstable angina. Am Heart J 135 (1998) 10-14
18. Virmani R., Kolodgie F.D., Burke A.P., et al. Atherosclerotic plaque progression and vulnerability to rupture. Angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25 (2005) 2054-2061
19. Doyle B., and Caplice N. Plaque neovascularization and antiangiogenic therapy for atherosclerosis. J Am Coll Cardiol 49 (2007) 2073-2080
20. Resar J.R., Roguin A., Voner J., et al. Hypoxia-inducible factor 1 alpha polymorphism and coronary collaterals in patients with ischemic heart disease. Chest 128 (2005) 787-791
21. Howell W.M., Ali S., Rose-Zerilli M.J., et al. VEGF polymorphisms and severity of atherosclerosis. J Med Genet 42 (2005) 485-490
22. Boekholdt S.M., Trip M.D., Peters R.J.G., et al. Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 22 (2002) e24-e27
23. Topol E.J., McCarthy J., Gabriel S., et al. Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation 104 (2001) 2641-2644